Cargando…

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

Osteoprotegerin (OPG) is a secreted member of the TNF receptor superfamily, which binds to the receptor activator of nuclear factor κB ligand (RANKL) and inhibits osteoclast activity and bone resorption. Systemic administration of recombinant OPG was previously shown to inhibit tumor growth in bone...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZINONOS, IRENE, LUO, KE-WANG, LABRINIDIS, AGATHA, LIAPIS, VASILIOS, HAY, SHELLEY, PANAGOPOULOS, VASILIOS, DENICHILO, MARK, KO, CHUN-HAY, YUE, GRACE GAR-LEE, LAU, CLARA BIK-SAN, INGMAN, WENDY, PONOMAREV, VLADIMIR, ATKINS, GERALD J., FINDLAY, DAVID M., ZANNETTINO, ANDREW C.W., EVDOKIOU, ANDREAS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091969/ https://www.ncbi.nlm.nih.gov/pubmed/24865346 http://dx.doi.org/10.3892/ijo.2014.2468

Ejemplares similares

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
por: Liapis, Vasilios, et al.
Publicado: (2017)

Plant-derived soybean peroxidase stimulates osteoblast collagen biosynthesis, matrix mineralization, and accelerates bone regeneration in a sheep model
por: Barker, Alexandra J., et al.
Publicado: (2021)

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
por: Bouralexis, S, et al.
Publicado: (2003)

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo
por: Zeissig, Mara N., et al.
Publicado: (2020)

Small extracellular vesicles deliver osteolytic effectors and mediate cancer‐induced osteolysis in bone metastatic niche
por: Ma, Qinyu, et al.
Publicado: (2021)

Evidence for Gender-Specific Bone Loss Mechanisms in Periprosthetic Osteolysis
por: Ormsby, Renee T., et al.
Publicado: (2019)

Characterization of the role of Samsn1 loss in multiple myeloma development
por: Friend, Natasha L., et al.
Publicado: (2020)

Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis
por: Liu, Guoyin, et al.
Publicado: (2015)

Deletion of Rptor in Preosteoblasts Reveals a Role for the Mammalian Target of Rapamycin Complex 1 (mTORC1) Complex in Dietary‐Induced Changes to Bone Mass and Glucose Homeostasis in Female Mice
por: Tangseefa, Pawanrat, et al.
Publicado: (2021)

Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk
por: Archer, Maddison, et al.
Publicado: (2021)

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models
por: Liapis, Vasilios, et al.
Publicado: (2021)

Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
por: Body, J. J., et al.
Publicado: (1997)

Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis
por: Alhasan, Hend, et al.
Publicado: (2022)

The role of peroxidasin in solid cancer progression
por: Wyllie, Kaitlin, et al.
Publicado: (2023)

Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis
por: Lloyd, Shane A, et al.
Publicado: (2014)

Antibody drug conjugates: hitting the mark in pancreatic cancer?
por: Wittwer, Nicole L., et al.
Publicado: (2023)

The RNA‐binding protein La/SSB associates with radiation‐induced DNA double‐strand breaks in lung cancer cell lines
por: Staudacher, Alexander H., et al.
Publicado: (2021)

BMP-2 functional polypeptides relieve osteolysis via bi-regulating bone formation and resorption coupled with macrophage polarization
por: Wang, Jiaqian, et al.
Publicado: (2023)

Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates
por: Staudacher, Alexander H, et al.
Publicado: (2018)

Osteolytic lesions (brown tumors) of primary hyperparathyroidism misdiagnosed as multifocal giant cell tumor of the distal ulna and radius: a case report
por: Panagopoulos, A., et al.
Publicado: (2018)

Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Osteolytic lesions in myelofibrosis
por: Johnson, Isla, et al.
Publicado: (2021)

Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption
por: Qin, An, et al.
Publicado: (2012)

Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
por: Khor, Ee Cheng, et al.
Publicado: (2013)

SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis
por: Jiao, Zixue, et al.
Publicado: (2023)

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo
por: Clark, Kimberley C., et al.
Publicado: (2020)

Acro-osteolysis
por: Thomas, Joe, et al.
Publicado: (2019)

Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023)

Tuberculosis of the foot: An osteolytic variety
por: Dhillon, Mandeep S, et al.
Publicado: (2012)

Solitary Tibial Osteolytic Lesion
por: Pakos, Emilios E., et al.
Publicado: (2009)

Pathological fracture on osteolytic lesion
por: Traore, Ousmane, et al.
Publicado: (2021)

Anti-oxidation Treatment of Ultra High Molecular Weight Polyethylene Components to Decrease Periprosthetic Osteolysis: Evaluation of Osteolytic and Osteogenic Properties of Wear Debris Particles in a Murine Calvaria Model
por: Green, Justin M., et al.
Publicado: (2013)

Pyroptosis in Periprosthetic Osteolysis
por: Yin, Jian, et al.
Publicado: (2022)

Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
por: Bradey, Alanah L., et al.
Publicado: (2022)

Immune Regulation of Mammary Fibroblasts and the Impact of Mammographic Density
por: Archer, Maddison, et al.
Publicado: (2022)

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer
por: Wittwer, Nicole L, et al.
Publicado: (2023)

Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models
por: Larrañaga-Vera, Ane, et al.
Publicado: (2022)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Osteolytic Skull Lesions–Our Experience
por: Sandeep, B. V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hlc76hrqdk6vh0f61vjo5c6q7r